HomeCompareALGN vs CB

ALGN vs CB: Dividend Comparison 2026

ALGN yields 1.20% · CB yields 1.19%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CB wins by $4.6K in total portfolio value
10 years
ALGN
ALGN
● Live price
1.20%
Share price
$166.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$130.06
Full ALGN calculator →
CB
CB
● Live price
1.19%
Share price
$325.35
Annual div
$3.88
5Y div CAGR
23.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.0K
Annual income
$1,241.17
Full CB calculator →

Portfolio growth — ALGN vs CB

📍 CB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALGNCB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALGN + CB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALGN pays
CB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALGN
Annual income on $10K today (after 15% tax)
$102.25/yr
After 10yr DRIP, annual income (after tax)
$110.55/yr
CB
Annual income on $10K today (after 15% tax)
$101.37/yr
After 10yr DRIP, annual income (after tax)
$1,054.99/yr
At 15% tax rate, CB beats the other by $944.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALGN + CB for your $10,000?

ALGN: 50%CB: 50%
100% CB50/50100% ALGN
Portfolio after 10yr
$23.7K
Annual income
$685.62/yr
Blended yield
2.89%
📊

Analyst Conviction Gap

Where Wall Street is split right now

ALGN
Analyst Ratings
24
Buy
7
Hold
2
Sell
Consensus: Buy
Price Target
$197.30
+18.7% upside vs current
Range: $140.00 — $220.00
Altman Z
4.9
Piotroski
7/9
CB
Analyst Ratings
1
Strong
22
Buy
18
Hold
2
Sell
Consensus: Buy
Price Target
$342.00
+5.1% upside vs current
Range: $305.00 — $373.00
Altman Z
1.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALGN buys
0
CB buys
0
No recent congressional trades found for ALGN or CB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALGNCB
Forward yield1.20%1.19%
Annual dividend / share$2.00$3.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%23.5%
Portfolio after 10y$21.4K$26.0K
Annual income after 10y$130.06$1,241.17
Total dividends collected$1.3K$5.2K
Payment frequencyquarterlyquarterly
SectorStockFinancials
Analyst consensusBuyBuy
Analyst price target$197.30$342.00

Year-by-year: ALGN vs CB ($10,000, DRIP)

YearALGN PortfolioALGN Income/yrCB PortfolioCB Income/yrGap
1← crossover$10,820$120.29$10,847$147.28$27.00CB
2$11,699$121.65$11,791$184.40$92.00CB
3$12,641$122.92$12,848$231.35$207.00CB
4$13,650$124.13$14,038$290.95$388.00CB
5$14,731$125.27$15,388$366.93$657.00CB
6$15,889$126.34$16,929$464.23$1.0KCB
7$17,128$127.36$18,703$589.49$1.6KCB
8$18,455$128.31$20,764$751.71$2.3KCB
9$19,876$129.21$23,181$963.24$3.3KCB
10$21,398$130.06$26,045$1,241.17$4.6KCB

ALGN vs CB: Complete Analysis 2026

ALGNStock

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Full ALGN Calculator →

CBFinancials

Chubb Limited provides insurance and reinsurance products worldwide. The company's North America Commercial P&C Insurance segment offers commercial property, casualty, workers' compensation, package policies, risk management, financial lines, marine, construction, environmental, medical, cyber risk, surety, and excess casualty; and group accident and health insurance to large, middle market, and small commercial businesses. Its North America Personal P&C Insurance segment provides affluent and high net worth individuals and families with homeowners, automobile and collector cars, valuable articles, personal and excess liability, travel insurance, and recreational marine insurance and services. The company's North America Agricultural Insurance segment offers multiple peril crop and crop-hail insurance; and coverage for farm and ranch property, and commercial agriculture products. Its Overseas General Insurance segment provides coverage for traditional commercial property and casualty; specialty categories, such as financial lines, marine, energy, aviation, political risk, and construction risk; and group accident and health, and traditional and specialty personal lines for corporations, middle markets, and small customers through retail brokers, agents, and other channels. The company's Global Reinsurance segment offers traditional and specialty reinsurance under the Chubb Tempest Re brand to property and casualty companies. Its Life Insurance segment provides protection and savings products comprising whole life, endowment plans, individual term life, group term life, medical and health, personal accident, credit life, universal life, and unit linked contracts. The company markets its products primarily through insurance and reinsurance brokers. The company was formerly known as ACE Limited and changed its name to Chubb Limited in January 2016. Chubb Limited was incorporated in 1985 and is headquartered in Zurich, Switzerland.

Full CB Calculator →
📬

Get this ALGN vs CB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALGN vs SCHDALGN vs JEPIALGN vs OALGN vs KOALGN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.